Acute Myeloid Leukemia with Trisomy 9 Following Chemotherapy of Non-Hodgkin's Lymphoma.
- Author:
Sung Won JANG
1
;
Dae Hoon LEE
;
Ju Yun CHOI
;
Hong Gi KIM
;
Min Ho CHOI
;
Sun Woo KIM
;
Jung Gon SUH
;
Jong Youl JIN
;
Dong Jip KIM
Author Information
1. Department of Internal Medicine, Catholic University College of Medicine, Korea.
- Publication Type:Original Article
- Keywords:
AML;
Trisomya;
Secondary leukemia
- MeSH:
Drug Therapy*;
Humans;
Leukemia, Myeloid, Acute*;
Lymphoma, Non-Hodgkin*;
Male;
Middle Aged;
Trisomy*
- From:Journal of the Korean Cancer Association
1997;29(3):512-515
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
A 56-year-old male patient with non-Hodgkin's lymphoma achieved complete remission in July 1994 after receiving MACOP-B chemotherapy. 29 months after treatment, acute myeloid leukemia (AML, FAB subtypes M4) with trisomy 9 was developed. To our knowledge this is the first report of therapy-related AML with trisomy 9.
